ArticleJournal of cancer research and clinical oncology2014

Does regular zoledronic acid change the bone turnover of the jaw in men with metastatic prostate cancer: a possible clue to the pathogenesis of bisphosphonate related osteonecrosis of the jaw?

Oliver Ristow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.